Advanced Heart Failure Clinical Trial
Official title:
Clinical Evaluation of the Carmat Total Artificial Heart for Patients With Advanced Heart Failure
The objective of this clinical investigation is to evaluate the safety and performance of the Carmat Total Artificial Heart (TAH) in subjects with advanced heart failure requiring biventricular support. Each subject receiving the Carmat TAH will be evaluated at 6 months (180 days) for primary and secondary endpoints with further follow-up assessments up to 2 years. The results of the study will be used to support a CE mark application.
Center selection is based on the following: experience with VAD/TAH implantation and record of good results in this patient population (% of survival), the infrastructure required to perform the clinical investigation (especially the surgical and cardiology teams); site resources and experience to manage the clinical study and the patient population; the adherence to the standards of Good Clinical Practice. A specific focus during the site selection is done on dedicated VAD - nurse team to ensure that: - Sites are experienced in the selection of patients whom require a mechanical circulatory support. Social and psychological conditions of the patient and family must be considered to ensure patient and family commitment in the care pathway, - Close supervision of patients on the use of the device (when changing batteries) by experienced hospital professionals is guarantee; - Extensive hospital training program and regular support for patients and family - relatives are ensured. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04915924 -
Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea
|
N/A | |
| Completed |
NCT01626404 -
Screening for Advanced Heart Failure Treatment (SEE-HF)
|
||
| Withdrawn |
NCT00572286 -
Non-invasive Evaluation of Heart Transplant Rejection- Pilot Study
|
N/A | |
| Completed |
NCT00690157 -
Registry of Patients Referred for Heart Transplantation
|
N/A | |
| Active, not recruiting |
NCT03874312 -
Ultrasound-assessed Internal Jugular Vein Distensibility in Advanced Chronic Heart Failure (US-IJVD in CHF)
|
||
| Enrolling by invitation |
NCT00988806 -
Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure
|
Phase 4 | |
| Recruiting |
NCT05284955 -
Screening for Advanced Heart Failure IN Stable outPatientS - The SAINTS Study (SAINTS B)
|
Phase 4 | |
| Completed |
NCT01643551 -
Neuron Specific Enolase in Ventricular Assist Device Recipients
|
N/A | |
| Terminated |
NCT04703855 -
Hong Kong and Taiwan HM3 PMS
|
N/A | |
| Suspended |
NCT04851236 -
Pilot Study of Massage Therapy to Improve Self Efficacy in Patients With Left-ventricular Device
|
Early Phase 1 | |
| Recruiting |
NCT03526627 -
Advanced Care Management in Patients With Advanced Heart Failure
|
||
| Recruiting |
NCT06228209 -
Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer
|
N/A | |
| Active, not recruiting |
NCT06259045 -
Cardiac Cachexia in Advanced Heart Failure
|
||
| Recruiting |
NCT05271214 -
Conservative Management of Left Ventricular Assist Device Candidates
|
||
| Recruiting |
NCT04475393 -
Carmat Total Artificial Heart as a Bridge to Transplant in Patients With Advanced Heart Failure
|
N/A | |
| Recruiting |
NCT03911349 -
Wrist Worn Blood Pressure Measurement
|
N/A | |
| Recruiting |
NCT03919136 -
Wrist Worn Blood Pressure Measurement
|
||
| Completed |
NCT01210573 -
Prospective Observation of Exercise Parameters in Advanced Heart Failure
|
N/A | |
| Recruiting |
NCT04423562 -
PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices
|